The news about Klay Thompson came mere days after the late-night revelation that teammate Kevin Durant would miss the entire 2019-20 NBA season with a ruptured Achilles tendon. Taken together, both injuries cast uncertainty over the Warriors’ long-term future — and further complicate a free-agency summer that already had promised to be one of the wildest ever.One-half of the Splash Brothers (with Stephen Curry), Thompson has been a founding member of this Warriors dynasty. He was drafted just two years after Curry — we don’t talk about that Ekpe Udoh pick sandwiched in between — and a year ahead of Draymond Green and Harrison Barnes, part of the masterful series of selections that laid the foundation for Golden State’s subsequent dominance. Since the Warrior dynasty’s first championship in 2014-15, Thompson ranks fifth on the team in both Value Over Replacement Player and Win Shares in the playoffs (behind Curry, Green, Durant and Andre Iguodala).Does that sound low? There’s a case to be made that the advanced metrics might perennially underrate Thompson on defense, where his reputation — he was named to the All-Defensive second team this season — vastly outstrips his statistical indicators. And although Thompson’s durability does factor into metrics such as VORP and Win Shares, he has played in 615 of 640 possible regular-season games (96 percent) in his career, providing a welcome sense of stability for a team all too familiar with injuries to stars.Certainly Thompson should get credit for the way his contract has enabled the Warriors to build their superteam around him. Thompson has often spoken about his love for playing in the Bay Area, and he’s pondered taking pay cuts to stay with the franchise. He was paid a comparatively modest $69 million these past four seasons as the Warriors won four straight conference championships and two titles (years when our CARMELO projections pegged his actual worth at $117 million).However, Thompson is due to become a free agent this summer, as part of a star-studded class that was also supposed to include his fellow Warrior Durant.1Assuming KD rejects his current contract’s option to remain with Golden State for the 2019-20 season. Because Thompson missed out on All-NBA recognition this season (it’s difficult to call it a “snub” given his good-but-not-great metrics), he won’t qualify for the NBA’s “supermax” category of extensions — which means the most he can make is about $190 million over five years if he re-signs with Golden State, or $141 over four years if he signs elsewhere. (By comparison, Curry re-signed for five years and $201 million two summers ago.)The timetable on recovering from ACL tears starts as low as seven months, but it generally requires nine months to a year before returning to the court. So Thompson probably will miss most (if not all) of the 2019-20 season with his injury, just like Durant. But in the wake of Durant’s injury, we already have seen reports that teams wouldn’t hesitate to sign KD to a maximum deal despite the uncertainty around his health. Thompson isn’t at the same level of franchise-altering stardom as Durant, but he is one year younger, and it wouldn’t be surprising to see rival teams take a similar approach to his free agency this summer.On the one hand, Thompson’s injury is a bad omen for a player whose game is built on a tremendous amount of high-stress activity. According to Second Spectrum data compiled by ESPN’s Stats & Information Group, no player in the NBA has run a greater distance over the past five seasons (including the playoffs) than the 1,267 miles Thompson covered. On the other hand, though, Thompson is a historically great shooter with one of the quickest releases the game has ever seen, so his skills figure to age well even if the injury costs him some athleticism.If the Warriors do part ways with both Thompson and Durant this summer, it’s worth wondering where the losses will leave a team that, not very long ago, looked like the most dominating force in the history of the NBA. According to the Elias Sports Bureau, a Golden State team without Klay, KD and a few other notable players who may depart has the potential to become just the fifth defending NBA Finalist ever to return less than half of its scoring from the previous season. (Thompson and Durant combined to score 3,707 of Golden State’s 9,650 points this season, or 38.4 percent, but the Warriors also have eight other players who aren’t under contract for 2019-20.) What happened to the other teams on the list?2Which were the 1998-99 Bulls, the 1948-49 Bullets, the 2004-05 Lakers and the 2018-19 Cavaliers. You don’t wanna know.3All finished with a losing record.The Warriors probably won’t fall quite so far; before the Thompson news, betting markets opened with Golden State as favorites to win the 2019-20 NBA championship, as the defending-champ Raptors dropped into a tie with the Houston Rockets for the fifth-best odds (behind the Warriors, Lakers, Bucks and Clippers). But those numbers are already destined to change with the reports about Thompson, so it’s just a question of how far Golden State falls — particularly relative to its two Western Conference challengers in Los Angeles, both of whom have designs on the summer’s top trade and free-agent targets. Will the Warriors not even be favored to win the West next year? That remains to be seen. But the severity of Thompson’s injury tacked another depressing note onto the end of Golden State’s season, and it adds another layer of uncertainty to the team’s future as a dynasty. The confetti had barely settled on the Toronto Raptors’ championship celebration before another stunning injury report hit their NBA Finals opponents, the Golden State Warriors, like a punch to the stomach:
Kolkata: The residential plots sold through e-auction in Action Area II in New Town by Housing Infrastructure Development Corporation (HIDCO), has evoked great response with one plot being sold for Rs 57 lakh per cottah.Twenty two out of 25 plots have already been sold and e-auction for the remaining three plots will be held on May 2. The highest price received so far is Rs 343 lakh for a 6 cottah plot. The average price for a cottah of land in the remaining 22 plots stands at Rs 38-39 lakh. The area of the plots measuring 5 cottah will be e-auctioned on May 2. These plots will be leased out for 99 years. Also Read – Heavy rain hits traffic, flightsHIDCO had decided to sell 100 plots in2017. Of these, 75 plots have been sold through lottery and the remaining 25 plots will be sold through e-auction. The first online booking for 75 plots began on January 28 in presence of Firhad Hakim, the state Urban Development minister.There were around 4,000 applicants for the 75 plots. Of the 75 plots, 58 plots were meant for individual houses, while the remaining 17 plots were meant to set up housing cooperatives. Of the 58 plots, 25 were reserved for people belonging to the middle income group (MIG) and the remaining 33 plots were for the people belonging to the higher income group (HIG). The area of the plots varied between 2.5 cottah and 5 cottah. Also Read – Speeding Jaguar crashes into Merc, 2 B’deshi bystanders killedThe population of New Town is 1 million, with 0.5 million additional floating population.New Town is a green city, where various steps have been taken to increase the green cover and conserve energy. The waste water is being recycled to water the roadside trees. Over the years, New Town has come up as an educational hub, with several private and state-run universities constructing their second campus there. It is the IT hub of Kolkata and has come up fast as a cultural centre as well. New Town is also the country’s first township, where cycle sharing scheme has been introduced and is becoming immensely popular. There are graded paths for bicycles. New Town also houses the country’s biggest convention centre.There had been several complaints against allotment of plots during the Left Front regime. The people were kept in the dark regarding the price of the plots. After coming to power in 2011, Chief Minister Mamata Banerjee had abolished the chairman’s quota and made a bureaucrat the chairman of HIDCO. The lottery to allot plots was also conducted maintaining clarity.
There are 29 million people living with diabetes in the U.S.—more than 9 percent of the population—at an annual cost of $245 billion. Even with an array of devices and drugs available to manage the condition, diabetes is the seventh-leading cause of death in the country.Rick Altinger, CEO of Palo Alto, Calif.-based Glooko, calls it an unnecessary pandemic. “Properly controlled, with the technology and devices we have today, you can live a healthy life,” he explains. “You don’t need to die from diabetes.”Managing the disease means careful monitoring of numerous variables, including blood sugar, medication and direct impact of food and exercise. “Today, there are people with Types 1 and 2 diabetes receiving suboptimal care. We don’t need to spend more money caring for them,” Altinger says. “We need to leverage big data and analytics.”Glooko, founded in 2010, is doing just that, with a diabetes-management platform sold directly to healthcare systems and insurance providers. Patients can use the system to tap into information about their food intake or exercise to make informed decisions; physicians and diabetes counselors can track and analyze a patient’s real-time progress, making them better equipped to adjust prescriptions and instructions.Patients can access the Glooko mobile app on their smartphones, while healthcare professionals use a kiosk mode to access analytics and create a road map for optimal care. “It’s not about cutting out or replacing the doctor,” Altinger says. “It’s the exact opposite. We want to enable doctors and nurses to be more involved.”The app has functions such as hypoglycemia monitoring, one of the most expensive aspects of diabetic care. Traditionally, a patient visits an endocrinologist, who pulls up data from the past few months and asks the patient to recount symptoms of a specific diabetic incident. Glooko’s real-time responsive module prompts a user to answer a series of questions to best determine what might have caused an incident and how to avoid a similar situation in the future. Altinger notes that over time, on-the-spot analysis of an incident or pattern can dramatically reduce care costs.Glooko also sells a proprietary Bluetooth-enabled blood-glucose meter that links to iOS and Android apps. Glooko’s products are cleared by the FDA, and the data collected is encrypted to meet privacy requirements of the Health Insurance Portability and Accountability Act. “You don’t want two guys in a garage throwing diabetes software into the app store and have your child or grandfather use it and put themselves at risk,” Altinger points out.Glooko’s formula offers a sweet deal to investors. In March the company closed a $16.5 million Series B round, bringing its total investment to $28 million.“Managing diabetes is a high-stakes, long-term proposition for patients and the healthcare system,” explains Wende Hutton, general partner at Menlo Park, Calif.-based Canaan Partners, the lead investor in Glooko’s latest round. She notes that diabetes is a “data-filled” disease that is “ripe for the kind of data-aggregation tools that Glooko can provide.“No other player has positioned itself in partnership with the diabetes-care suppliers like Glooko has,” Hutton adds. “We found that to be very compelling in offering a comprehensive solution set that could be easily adopted and implemented by the healthcare system.” Attend this free webinar and learn how you can maximize efficiency while getting the most critical things done right. Free Webinar | Sept 5: Tips and Tools for Making Progress Toward Important Goals September 11, 2015 This story appears in the September 2015 issue of Entrepreneur. Subscribe » 3 min read Register Now »